Qsemble Capital Management’s Astera Labs ALAB Stock Holding History

Qsemble Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,436	Closed	-$323K	–	599
2024 Q4	$323K	Buy	+2,436	New	+$229K	0.04%	326

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qsemble Capital Management's ALAB Position: Q1 2025 in Review

Qsemble Capital Management sold out of Astera Labs (ALAB) in Q1 2025, closing a stake of 2,436 shares — an estimated $323K sold.

Qsemble Capital Management first reported a position in ALAB in Q4 2024 and held it in 1 quarter. The position peaked at $323K in Q4 2024. 391 funds tracked by Wall St. Rank hold ALAB as of Q1 2025.

Qsemble Capital Management reported no remaining Astera Labs position as of Q1 2025 after selling out during the quarter.
Qsemble Capital Management sold 2,436 Astera Labs shares in Q1 2025, an estimated $323K.
Qsemble Capital Management first reported a position in Astera Labs in Q4 2024 and held it in 1 quarter.
Qsemble Capital Management's Astera Labs position peaked at $323K in Q4 2024.
391 funds tracked by Wall St. Rank held Astera Labs as of Q1 2025.

Based on Qsemble Capital Management's 13F filing for Q1 2025, filed 12 May 2025.